INSIGHTS ON CLINICAL TRIAL DESIGN
-
At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights
Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.
-
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
-
Optimizing Movement Disorder Clinical Trials: A Focus On Parkinson's Disease
Join DVCR experts for a presentation on designing effective Parkinson's clinical trials. This webinar covers endpoint selection, patient-centered design, and real-world case studies.
-
Meeting Regulatory And Patient Needs By Improving Clinical Trial Access
Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.
-
Critical Inputs For Configuring An RTSM3/25/2026
Uncover why clearly defined visit schedules and dispensing events are essential in RTSM design — and how resolving protocol ambiguity early prevents downstream complexity across systems and sites.
-
Analyzing The FDA's Approach To Diversity In Clinical Trials1/31/2025
Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
Rapid Expansion Of Peptide And Nanobody Drug Conjugates7/21/2026
Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.
-
Early Oncology Clinical Trials: Key Considerations To Plan For Success5/14/2025
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
-
The Hidden Healthcare Benefits That Home Trial Support Provides7/22/2025
Examine how Home Trial Support (HTS) enhances both patient and caregiver safety and well-being, while alleviating pressures on sites and generating greater ROI for sponsors.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
-
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.
-
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.